Eurointervention

Papers
(The TQCC of Eurointervention is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Supporting evidence for ST-segment elevation myocardial infarction from optical coherence tomography216
Letter: ORBITA-2 trial design and rationale: what causes angina after PCI?107
Intracoronary polarimetry of a honeycomb-like structure87
Thirty years of transradial coronary interventions87
In search of the “IDEAL” left main coronary stent and DAPT regimen78
Deep learning for prediction of fractional flow reserve from resting coronary pressure curves73
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement70
Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated!63
Impella – a treatment for all STEMI patients with cardiogenic shock? The effect of off-hours admission58
Robotic-assisted percutaneous coronary intervention: the future or the past?57
Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial54
Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged52
Double-tap to treat paravalvular leak in high-risk annuli50
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias48
The patent foramen ovale does not spontaneously close in patients aged 6046
Reply: Identifying vulnerable coronary atherosclerotic plaques: from theory to practice45
Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow42
ACURATE neo2: jack of all trades or master of none?41
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial41
Clinical impact of intervention strategies after failed transcatheter mitral valve repair39
Mechanical thrombectomy for pulmonary embolism revisited: technological breakthrough or simple renovation?39
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity39
Management of a giant dual-chamber pseudoaneurysm of the proximal left anterior descending artery38
Targeting inflammation in atherosclerosis: overview, strategy and directions38
In search of the origin of the acronym TAVI37
Transcatheter heart valve thrombosis on the mitral stage: “The Tempest” or “Much Ado About Nothing”?36
The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation35
Transcatheter left ventriculoplasty35
Outcomes of directional atherectomy for common femoral artery disease34
Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessment32
Reply: When is the optimal time point for detecting malapposition in coronary bifurcation trials?31
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis30
Transcatheter tricuspid interventions are performed too late: pros and cons28
Reviewing scientific manuscripts in 2023: is it (still) worth the time?26
First-in-human description of a novel transcatheter tricuspid valve prosthesis to preserve the asymmetric shape of the right ventricle26
TAVR under 70: is age just a number?26
Fatal acute mesenteric ischaemia following transcatheter aortic valve replacement25
Outcomes of valve-in-valve transcatheter aortic valve implantation with and without bioprosthetic valve fracture25
Breaking down the barriers in the management of INOCA: how can we do better in the diagnosis of coronary vasomotor disorders?25
Pressure-bounded coronary flow reserve to assess the extent of microvascular dysfunction in patients with ST-elevation acute myocardial infarction25
Letter: Pretreatment with unfractioned heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?25
Prevalence and patterns of in-stent neoatherosclerosis in lower extremity artery disease24
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention24
Reconsidering the evidence for CTO PCI: the devil is in the detail24
Transcatheter aortic valve implantation: the shape matters23
Transapical transcatheter mitral valve implantation in patients with prior aortic valve replacement: a feasibility report22
Predictors of non-stenting strategy for acute coronary syndrome caused by plaque erosion: four-year outcomes of the EROSION study22
Computer-based prediction of coronary artery compression in the planning of transcatheter pulmonary valve implantation22
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis22
Reply: Composite endpoints in clinical trials - simplicity or perfection?22
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis21
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair21
Radial wall strain: a novel angiographic measure of plaque composition and vulnerability21
International variation in modality and outcomes of left main revascularisation: does it really matter?21
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study21
Temporal trends in characteristics of patients undergoing transcatheter tricuspid edge-to-edge repair for tricuspid regurgitation21
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions20
Recanalisation of coronary chronic total occlusions20
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and19
Principles and pitfalls in coronary vasomotor function testing18
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s18
Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation18
How to set up regional STEMI networks: a "Stent - Save a life!" initiative17
Intravascular ultrasound guidance for lower extremity arterial and venous interventions17
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry17
Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial16
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation16
A staging classification of right heart remodelling for patients undergoing transcatheter edge-to-edge mitral valve repair16
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis16
Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial15
Comprehensive diagnosis in chronic coronary syndromes combining angiography and intracoronary testing: the AID-ANGIO study15
Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial15
Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation15
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions 15
Transcatheter valve repair in congenitally corrected transposition of the great arteries14
Echocardiographic guidance in transcatheter structural cardiac interventions14
A direct wire pacing device for transcatheter heart valve and coronary interventions: a first-in-human, multicentre study of the Electroducer Sleeve14
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry14
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve14
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation13
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin13
Managing the device-related risk of in-stent restenosis and stent thrombosis in coronary stenting13
Reply: Pretreatment with unfractionated heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?13
A study of the novel SinoCrown system for transcatheter aortic valve implantation13
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial13
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?13
STEMI outcomes in the era of COVID-19: reaffirmation of an unfortunate reality13
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the Eur13
Standardisation of techniques for bifurcation stenting optimisation: the journey continues12
Catheter directed therapies: an option for elderly frail patients with pulmonary embolism requiring reperfusion12
Valve-in-valve TAVI: the new standard therapy for failing bioprosthetic valves?12
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation12
Bicuspid is different12
Stent underexpansion in the CRUNCH registry: worth cracking?12
TAVI in moderate aortic stenosis and heart failure: pros and cons12
Do we need another device for catheter interventional closure of septum secundum atrial septal defects?12
Percutaneous tricuspid valve annuloplasty: additional data and remaining questions12
Redo-TAVI with a balloon-expandable valve and the impact of index transcatheter aortic valve design12
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?11
Durability of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: the last missing piece?11
Transseptal puncture in patients with septal occluder devices during catheter ablation of atrial fibrillation11
Some endotypes of microvascular dysfunction may be more worrisome than others11
Heparin pretreatment in STEMI: is earlier always better?11
To be better among the best: a difficult task11
Redo-TAVI feasibility and coronary accessibility following index TAVI with the Evolut valve in patients with bicuspid aortic valve stenosis11
0.11562895774841